|
| |
 |
| REVIEW ARTICLE |
|
| Year : 2018 | Volume
: 8
| Issue : 1 | Page : 1-5 |
|
Primary laryngeal tuberculosis: A frequently misdiagnosed disease
Santosh Kumar Swain1, Mahesh Chandra Sahu1, Sitanshu Sekhar Kar2
1 Department of Otorhinolaryngology, IMS and SUM Hospital, Siksha “O” Anusandhan University, Bhubaneswar, Odisha, India
2 Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
| Date of Web Publication | 8-May-2019 |
Correspondence Address:
Prof Santosh Kumar Swain
Department of Otorhinolaryngology, IMS and SUM Hospital, Kalinga Nagar, Bhubaneswar - 751 003, Odisha
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jlv.JLV_5_18
 Abstract | | |
Primary laryngeal tuberculosis (PLT) is a granulomatous infection of the larynx caused by Mycobacterium tuberculosis without affecting the lungs. It is a rare type of extrapulmonary tuberculosis seen in clinical practice. After the introduction of antitubercular therapy (ATT), the incidence of LT is reduced and remains stable. However, the incidence of PLT is increasing due to acquired immune deficiency syndrome epidemic. The important clinical presentations of PLT are dysphonia and odynophagia. The diagnosis is confirmed by histopathological examination as it often mimics laryngeal malignancy. The treatment is ATT, whereas surgery is only reserved in certain situations where is compromising the laryngeal airway by its granulomatous growth. Delayed or misdiagnosis or untreatable LT will lead to high morbidity and mortality of a patient. Although primary tubercular lesion has nonspecific clinical presentations, it is very important to have a high index of suspicions to rule out tubercular lesion in the larynx as this disease is a curable one.
Keywords: Antitubercular therapy, extrapulmonary, histopathology, larynx, primary laryngeal tuberculosis
How to cite this article:
Swain SK, Sahu MC, Kar SS. Primary laryngeal tuberculosis: A frequently misdiagnosed disease. J Laryngol Voice 2018;8:1-5 |
| Introduction | |  |
Tuberculosis is a granulomatous infectious disease caused by Mycobacterium tuberculosis. This disease mainly affects lungs called as pulmonary tuberculosis but can also affect extrapulmonary site such as larynx. Tuberculosis is a major public health problem in developing and underdeveloped countries. It often affects the lungs causing pulmonary tuberculosis, which accounts for 80% of the cases.[1] However, it can involve any other organ of the human body. Laryngeal tuberculosis (LT) is a rare type of extrapulmonary tuberculosis, which constitutes <1% of all types of tuberculosis cases.[2] Due to higher number of immunocompromised persons and rising multidrug-resistant tuberculosis cases, there more number of primary LT (PLT) nowadays. Approximately 530,000 children are suffering with tuberculosis in the developing countries around the world.[3] The extrapulmonary involvement of tuberculosis ranges from 30% to 40%.[4] Larynx is an uncommon site for tuberculosis in the community. PLT may cause mild hoarseness of voice to severe odynophagia and dyspnea due to laryngeal edema and granulations. A clinician or an otorhinolaryngologist should be familiar with unusual site like larynx for tuberculosis. Currently, the worldwide recrudescence of tuberculosis caused due to spread of human immunodeficiency virus (HIV) infection infection. The presentation is often misleading confused with laryngeal cancer. Due to nonspecific clinical presentations and relative lack of familiarity of this lesion amoung clinician, this may lead to the misdiagnosis of PLT. This review article discusses the etiopathology, clinical presentation, investigations, and treatment of PLT. This must be considered in the interest for avoiding misdiagnosis, inappropriate treatment, and untoward outcomes for not only the patient but also the public as well.
| Etiopathology | | |
PLT is a rare clinical entity and often caused by direct invasion of the inhaled M. tuberculosis bacilli.[5] Secondary involvement of the larynx occurs by cough and expectoration from tracheobronchial tree or through bloodstream from other than lungs.[6] Lymphatic spread to the larynx is rare. Laryngeal sites affected by tuberculosis in the decreasing order is as follows: true vocal folds (50%–70%), false cords (40%–50%), epiglottis, aryepiglottic folds, arytenoids, posterior commissure, and/or subglottis (10%–15%).[6] The tubercular lesions in the different parts of the larynx may appear as ulcerative [Figure 1], ulcero-fungative, granulomatous lesions [Figure 2], polypoidal [Figure 3], or nonspecific inflammatory.[7] Congestion of unilateral vocal cord should alert one for the possibility of tubercular lesion. The lesions of PLT may mimic leukoplakia, chronic laryngitis, or laryngeal candidiasis.[8] It can affect any part of the larynx.[9] The vocal cords of the larynx are commonly affected in LT. LT is characterized by edema, hyperemia, or ulcerative lesions in the larynx. Arytenoids, posterior commissure, and epiglottis are affected in LT if it coexists with pulmonary tuberculosis. LT is a highly contagious disease of the human being. LT is often associated with pulmonary tuberculosis,[10] but a patient also has LT without a history of pulmonary tuberculosis in case PLT.[11] PLT mostly occurs in adult males aged between 40 and 50 years.[11] It is often seen in persons without BCG vaccination, with malnutrition or in patients of acquired immunodeficiency syndrome, low immunity, and chronic smoking.[10] Of the different predisposing factors, alcohol abuse and smoking are the two known risk factors for PLT.[12] The link between the HIV infection and tuberculosis is documented in the literature.[13] Congestion of unilateral vocal cord should alert the physician for a possible of tubercular lesion. Smoking habit of a person aggravates LT. Smoking affects the mucosa of the larynx by chronic stimulation and causes decrease defensive capability of the larynx.[14] This consideration suggests that mucosal membrane of the larynx is inflamed by smoking and may be more likely affected by the transairway infection from the tuberculosis and so lead to more progressive LT. PLT has no gender or age predilection. | Figure 1: Ulcerative lesions on the vocal folds in primary tubercular laryngitis
Click here to view |
 | Figure 2: Granulomatous lesion on the arytenoids in primary tubercular laryngitis (arrow mark)
Click here to view |
 | Figure 3: Polypoidal lesion on the vocal fold in primary tubercular laryngitis (arrow mark)
Click here to view |
| Epidemiology | | |
“Captain of all these men of death” is referred to tuberculosis by John Bunyan in the 18th century, which is still the biggest health challenge to the world.[15] The prevalence of tuberculosis is more in underdeveloped and some developing countries of the world. Tuberculosis is the most common cause for death all over the world which includes a quarter of all avoidable death globally.[15] The World Health Organization (WHO) documented that India has the highest incidence of tuberculosis, accounting 168 cases per one lakh population (approximately 42 times the incidence of North America which is 4 per 1 lakh).[16] Extrapulmonary tuberculosis constitutes approximately 25%, of which 10%–35% of the cases at the head and neck area.[17] About 14% of the pulmonary tuberculosis patients are associated with extrapulmonary involvement.[18] Tubercular cervical lymphadenopathy is the most common manifestation in head and neck tubercular lesions followed by tubercular otitis media and LT.[19] LT is a rare type of extrapulmonary tuberculosis which constitutes <1% of all types of tuberculosis cases.[2] Due to higher number of immunocompromised persons and rising of multidrug-resistant tuberculosis cases, there is more number of LT nowadays. The prevalence of HIV infection associated with tuberculosis is 8.8%, which increases the mortality of the patient by 33%.[20]
| Clinical Presentations | | |
The tuberculosis of the larynx often presents with hoarseness of voice (80%–100%) and odynophagia (50%–67%), which often mimic other laryngeal diseases also.[21] It may lead to severe dyspnea and stridor due to laryngeal edema and granulations. Hoarseness of voice is the most common clinical presentation, but odynophagia and dyspnea can also be present in case of PLT patients. The constitutional clinical symptoms such as fatigue, weight loss, fever, night sweats, and hemoptysis are often seen in these patients. The clinical signs are often minor in primary tubercular lesions of the larynx and the features such as fever, weight loss, and asthenia are essentially seen in the advanced form of isolated laryngeal tuberculosis with severe odynophagia. The gross laryngoscopic lesions vary from ulcerative lesions to hypertrophic exophytic and polypoid lesions.[22] The macroscopic appearance of PLT is classified into four types: granulomatous, polypoid, ulcerative, and nonspecific. The lesions are either single or multiple. Granulomatous lesions in LT are more common in patients among pulmonary tuberculosis coexisting with laryngeal lesion.[23] The family should be screened as members suffering from tuberculosis may spread bacilli directly to the larynx through inhalation. The differential diagnoses of PLT are syphilis, neoplasm, sarcoidosis, Wegener's disease, leprosy, actinomycosis, lupus, recurrent polychondritis, rheumatoid arthritis, and amyloidosis.[24]
| Investigations | | |
PLT is a very uncommon clinical entity and often mimics malignancy in imaging or during laryngoscopy examination.[10] The diagnosis of LT is based on pathological and microbiological findings of the biopsy specimen collected from the larynx [Figure 4]. Diagnosis of PLT is confirmed by histopathological examinations with chronic granulomatous inflammatory exudates with or without caseating necrosis. In some cases of histopathology, picture shows the absence of caseations where the diagnosis is confirmed by recovery of the patients under antitubercular therapy (ATT). Routine blood investigations such as total white cell counts, differential count, and erythrocyte sedimentation rate (ESR) are done in all cases. Blood investigations are often normal, except a slight increase of activated protein C and erythrocyte sedimentation rate. Anti-streptolysin O titers may be elevated. Mantoux test and QuantiFERON assay are often positive.[25] Tuberculin test is also advised in all cases. The tuberculin test is also known as Mantoux test which is a standard procedure during the diagnosis of tuberculosis. It includes intradermal inoculation of purified protein which is derived from M. tuberculosis for assessing the cellular immune response to the antigens. The inflammatory reaction occurs in M. tuberculosis-sensitized patients. The observation of reaction is done after 48–72 h and is valid for 7 days. The evaluation of tuberculin test is based on the diameter of the inflammatory area calculated transversally against the longitudinal direction of the challenged forearm. The inflammation area >10 mm in immunocompetent persons is considered a positive result. The inflammatory area >5 mm in immunocompromised patient indicates positive for tuberculosis. The Mantoux test although used for diagnosis of tuberculosis, it has certain limitations such as the low sensitivity in immunocompromised patients, difficult in children, subjective character of interpretation.[26] ESR and Mantoux tests should not be used for diagnosis but are much helpful in pursuing the patients and subjecting for further investigation on strong clinical suspicion. Sputum microscopy for acid-fast bacilli (AFB) is positive in around 20% of the cases of LT and most of the chest X-ray findings are consistent with pulmonary tuberculosis.[27] Ziehl–Neelsen staining may directly show AFB. The microbiological culture and drug sensitivities of the infective strain are not usually done in practice, whereas the multiple repeated biopsies are often used for confirming the diagnosis and starting the treatment.[28] The polymerase chain reaction (PCR) test is used for the confirmation of tuberculosis. The detection of M. tuberculosis is increased from 2% to 17% on culture to 89%–100% in PCR.[29] In cases of strong clinician suspicion of tuberculosis with negative cultures, samples can be sent for PCR test.[17] QuantiFERON-TB Gold In-Tube (QFT-GIT) is an interferon gamma release assay (IGRA) which is often used to detect tuberculosis. It is an in vitro diagnostic test which needs blood drawn. As per the updated guidelines for IGRAs to find out M. tuberculosis, the QFT-GIT holds promise.[30] | Figure 4: (a) Histopathological examination showing granuloma formation with caseous necrosis. (b) Ziehl–Neelsen staining from biopsy specimens showing acid-fast bacilli
Click here to view |
| Treatment | | |
LT responds well to ATT. The treatment of LT is similar to pulmonary tuberculosis with surgical intervention to ensure patent and safe airway if laryngeal airway is threatened by tubercular granuloma. As per the WHO guidelines, LT or extrapulmonary tuberculosis should be treated with four-drug regimen for 2 months followed by two drugs for next 4 months.[31] ATT is the cornerstone of treatment for this disease, and the role of surgery is only done for early diagnosis and maintaining airway if compromised.[32] The drug combination used includes isoniazid, rifampicin, ethambutol, and pyrazinamide for 2 months followed by isoniazid and rifampicin for 4 months.[33] However, in case of drug-resistant M. tuberculosis, these guidelines are not appropriate where more drugs are used or treatment is prolonged.[34] Many otolaryngologists may not familiar with clinical presentations and treatment of LT due to paucity of this type of cases. To avoid untoward outcomes amoung patients suffering from this lesion, healthcare workers and public at large should be targeted to improve awareness. It is also vital for the physicians to be familiar with this contagious disease like LT.
| Conclusion | | |
PLT is a rare clinical entity in comparison to pulmonary tuberculosis, but nowadays, its incidence is rising in endemic area. It should be considered as a differential diagnosis in case of ulcerative or any inflammatory swelling of the vocal fold. Abnormal chest X-ray showing the features of tuberculosis along with laryngeal lesion suggests the diagnosis, whereas normal chest X-ray cannot exclude the diagnosis. Hence, the clinician should keep in mind the existence of PLT thus avoiding delayed treatment. Delayed diagnosis or untreated LT will lead to high morbidity and mortality of the patient. Although it has nonspecific clinical presentations, it is very important to have a high index of suspicion to rule out tubercular lesion in the larynx as this disease is curable.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Bruzgielewicz A, Rzepakowska A, Osuch-Wójcikewicz E, Niemczyk K, Chmielewski R. Tuberculosis of the head and neck – Epidemiological and clinical presentation. Arch Med Sci 2014;10:1160-6.  |
| 2. | Uslu C, Oysu C, Uklumen B. Tuberculosis of the epiglottis: A case report. Eur Arch Otorhinolaryngol 2008;265:599-601. |
| 3. | World Health Organization. Global Tuberculosis Report 2013. Geneva: World Health Organization; 2013. |
| 4. | World Health Organization. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. Geneva: World Health Organization; 2014. |
| 5. | Swain SK, Behera IC, Sahu MC. Primary laryngeal tuberculosis: Our experiences at a tertiary care teaching hospital in Eastern India. J Voice 2018. pii: S0892-1997(18)30085-7. |
| 6. | Unal M, Vayisoglu Y, Guner N, Karabacak T. Tuberculosis of the aryepiglottic fold and sinus pyriformis: A rare entity. Mt Sinai J Med 2006;73:806-9. |
| 7. | Shin JE, Nam SY, Yoo SJ, Kim SY. Changing trends in clinical manifestations of laryngeal tuberculosis. Laryngoscope 2000;110:1950-3. |
| 8. | Chen H, Thornley P. LT: A case of a non-healing laryngeal lesion. Australas Med J 2012;5:175-7. |
| 9. | Gassab E, Kedous S, Berkaoui A. Extra-nodal head and neck tuberculosis. J Tun Orl 2010;24:26-30. |
| 10. | El Kettani NE, El Hassani M, Chakir N, Jiddane M. Primary laryngeal tuberculosis mimicking laryngeal carcinoma: CT scan features. Indian J Radiol Imaging 2010;20:11-2. |
| 11. | Wang CC, Lin CC, Wang CP, Liu SA, Jiang RS. Laryngeal tuberculosis: A review of 26 cases. Otolaryngol Head Neck Surg 2007;137:582-8. |
| 12. | Kossowski M, Conessa C, Clement P, Roguet E, Verdalle P, Poncet JL. Current aspects of laryngeal tuberculosis: about 4 cases. Ann Otolaryngol Chir Cervicofac 2002;119:281-6. |
| 13. | El Ayoubi F, Chariba I, El Ayoubi A, Chariba S, Essakalli L. Primary tuberculosis of the larynx. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:361-4. |
| 14. | Kurokawa M, Nibu K, Ichimura K, Nishino H. Laryngeal tuberculosis: A report of 17 cases. Auris Nasus Larynx 2015;42:305-10. |
| 15. | Yashveer JK, Kirti YK. Presentations and challenges in tuberculosis of head and neck region. Indian J Otolaryngol Head Neck Surg 2016;68:270-4. |
| 16. | World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report 2008. World Health Organization; 2008. |
| 17. | Menon K, Bem C, Gouldesbrough D, Strachan DR. A clinical review of 128 cases of head and neck tuberculosis presenting over a 10-year period in Bradford, UK. J Laryngol Otol 2007;121:362-8. |
| 18. | Swarna Nantha Y. A review of tuberculosis research in Malaysia. Med J Malaysia 2014;69 Suppl A: 88-102. |
| 19. | Akkara SA, Singhania A, Akkara AG, Shah A, Adalja M, Chauhan N, et al. A study of manifestations of extrapulmonary tuberculosis in the ENT region. Indian J Otolaryngol Head Neck Surg 2014;66:46-50. |
| 20. | Vaid S, Lee YY, Rawat S, Luthra A, Shah D, Ahuja AT, et al. Tuberculosis in the head and neck – A forgotten differential diagnosis. Clin Radiol 2010;65:73-81. |
| 21. | Du H, Cai G, Ge S, Wang CI, Zhou L. Secondary LT in Tibet China: A report of six cases. Otolaryngol Case Rep 2017;2:26-8. |
| 22. | Lim JY, Kim KM, Choi EC, Kim YH, Kim HS, Choi HS, et al. Current clinical propensity of laryngeal tuberculosis: Review of 60 cases. Eur Arch Otorhinolaryngol 2006;263:838-42. |
| 23. | Nalini B, Vinayak S. Tuberculosis in ear, nose, and throat practice: Its presentation and diagnosis. Am J Otolaryngol 2006;27:39-45. |
| 24. | Richter B, Fradis M, Köhler G, Ridder GJ. Epiglottic tuberculosis: Differential diagnosis and treatment. Case report and review of the literature. Ann Otol Rhinol Laryngol 2001;110:197-201. |
| 25. | Giacomet V, Bonardi CM, Paradiso L, Coletto S, Vigano A, Fabiano V, et al. A case of LT in a pediatric patient. Asian Pac J Trop Dis 2014;4:656-8. |
| 26. | González-Martín J, García-García JM, Anibarro L, Vidal R, Esteban J, Blanquer R, et al. Consensus document on the diagnosis, treatment and prevention of tuberculosis. Arch Bronconeumol 2010;46:255-74. |
| 27. | Shital P, Mirza M. Laryngeal & lower lung field tuberculosis in pregnancy: A. Eur J Gen Med 2018;15:76-80. |
| 28. | Prstačić R, Jurlina M, Žižić-Mitrečić M, Janjanin S. Primary nasopharyngeal tuberculosis mimicking exacerbation of chronic rhinosinusitis. J Laryngol Otol 2011;125:747-9. |
| 29. | Geier J, Orlando B. Pulmonary and laryngeal tuberculosis in a 25-weeks' gestation parturient, diagnosed after failed tracheal intubation. Int J Obstet Anesth 2018;33:75-7. |
| 30. | Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection – United States, 2010. MMWR Recomm Rep 2010;59:1-25. |
| 31. | WHO, World Health Organization. Guidelines on the management of latent tuberculosis infection. World Health Organization; 2015. |
| 32. | Michael RC, Michael JS. Tuberculosis in otorhinolaryngology: Clinical presentation and diagnostic challenges. Int J Otolaryngol 2011;2011:686894. |
| 33. | Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med 2001;345:189-200. |
| 34. | Bosch A, Conrad A, Fuchsmann C, Prot B, Dumitrescu O, Ferry T, et al. Severe laryngeal and pulmonary tuberculosis under anti-TNF-α therapy. Int J Infect Dis 2018;71:65-6. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
|
